(NYSE:MD) MEDNAX Inc Dips To New 52 Week Low

MD
MD

MEDNAX Inc (NYSE:MD)

April 16th, 2019

Amidst rising markets MEDNAX Inc finished Tuesday’s trading session down 3.27%, a ($0.90) decrease to close on $26.66. As well as the drop in value, MEDNAX Inc hit a new 52 week low of $26.60, breaking the previous low of $26.97 from earlier this December. It’s expected that MEDNAX Inc will report earnings within the next couple of weeks.

Expectations from 13 analysts points to the possibility that MEDNAX Inc could increase significantly (39.84%), while Finbox has calculated (with very high uncertainty) a fair value price of $46.84.

Market Sectors

The market sectors were mixed Tuesday with a majority of the sectors trending up. Financials saw the biggest increase of the day (1.37%), while Real Estate saw the biggest drop (-2.38%). Information Technology has seen the biggest year-to-date gain at 23.78%.

Energy saw the biggest turnaround from its 5-day performance of -1.22%, as it went up 0.64%. Real Estate and Utilities both saw turn arounds from their five day positive performance, Real Estate with a drop of -2.38%.

Sector Breakdown

  • Financials went up with a 1.37% change.
  • Energy went up with a 0.64% change.
  • Industrials went up with a 0.59% change.
  • Information Technology went up with a 0.49% change.
  • Consumer Discretionary went up with a 0.48% change.
  • Materials went up with a 0.47% change.
  • Communication Services went up with a 0.21% change.
  • Consumer Staples went down with a -0.06% change.
  • Utilities went down with a -1.39% change.
  • Healthcare went down with a -2.03% change.
  • Real Estate went down with a -2.38% change.

MEDNAX Inc Info

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of December 31, 2018, it had a network of approximately 4,210 affiliated physicians. The company was founded in 1979 and is based in Sunrise, Florida.

All amounts in USD unless otherwise indicated

MD daily update
MD daily update

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.

This site uses Akismet to reduce spam. Learn how your comment data is processed.